Patents by Inventor Mauro Anibaldi
Mauro Anibaldi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10787469Abstract: A process for the purification of L-?-glycerophosphorylcholine is described, wherein L-?-glycerophosphorylcholine is crystallized from DMSO or from a mixture of DMSO with at least another solvent, preferably selected from water, alcohol, halogenated solvents, ethers, esters and/or amides. Such a process allows to obtain L-?-glycerophosphorylcholine having a purity greater than 99.5%, preferably greater than 99.7%, even more preferably greater than or equal to 99.9%. A method for determining the purity of L-?-glycerophosphorylcholine is also described, comprising the elution of L-?-glycerophosphorylcholine through an HPLC column having an amino stationary phase, and subsequent detection of L-?-glycerophosphorylcholine itself, and any impurity thereof, by means of an Evaporative Light Scattering Detector type.Type: GrantFiled: March 21, 2019Date of Patent: September 29, 2020Inventors: Lorenzo De Ferra, Mauro Anibaldi, Maurizio Zenoni, Fabrizio Cocchi
-
Publication number: 20190218234Abstract: A process for the purification of L-?-glycerophosphorylcholine is described, wherein L-?-glycerophosphorylcholine is crystallized from DMSO or from a mixture of DMSO with at least another solvent, preferably selected from water, alcohol, halogenated solvents, ethers, esters and/or amides. Such a process allows to obtain L-?-glycerophosphorylcholine having a purity greater than 99.5%, preferably greater than 99.7%, even more preferably greater than or equal to 99.9%. A method for determining the purity of L-?-glycerophosphorylcholine is also described, comprising the elution of L-?-glycerophosphorylcholine through an HPLC column having an amino stationary phase, and subsequent detection of L-?-glycerophosphorylcholine itself, and any impurity thereof, by means of an Evaporative Light Scattering Detector type.Type: ApplicationFiled: March 21, 2019Publication date: July 18, 2019Applicant: Chemi S.P.A.Inventors: Lorenzo De Ferra, Mauro Anibaldi, Maurizio Zenoni, Fabrizio Cocchi
-
Publication number: 20170101425Abstract: A process for the purification of L-?-glycerophosphorylcholine is described, wherein L-?-glycerophosphorylcholine is crystallized from DMSO or from a mixture of DMSO with at least another solvent, preferably selected from water, alcohol, halogenated solvents, ethers, esters and/or amides. Such a process allows to obtain L-?-glycerophosphorylcholine having a purity greater than 99.5%, preferably greater than 99.7%, even more preferably greater than or equal to 99.9%. A method for determining the purity of L-?-glycerophosphorylcholine is also described, comprising the elution of L-?-glycerophosphorylcholine through an HPLC column having an amino stationary phase, and subsequent detection of L-?-glycerophosphorylcholine itself, and any impurity thereof, by means of an Evaporative Light Scattering Detector type.Type: ApplicationFiled: June 9, 2015Publication date: April 13, 2017Inventors: Lorenzo De Ferra, Mauro Anibaldi, Maurizio Zenoni, Fabrizio Cocchi
-
Patent number: 9266863Abstract: Described herein is a process for the synthesis of azacitidine or decitabine, comprising the silylation of azacytosine in the presence of N,O-bis-trimethylsilyl-trifluoroacetamide. Such reaction is performed in an organic solvent, preferably aprotic, even more preferably selected from among dichloromethane, dichloroethane and/or acetonitrile. According to a further aspect of the process, 2 to 3 moles of N,O-bis-trimethylsilyl-trifluoroacetamide are used per mole of azacytosine, preferably from 2.2 to 2.5.Type: GrantFiled: March 28, 2011Date of Patent: February 23, 2016Assignee: CHEMI SPAInventors: Lorenzo De Ferra, Maurizio Zenoni, Stefano Turchetta, Mauro Anibaldi, Ettore Ammirati, Paolo Brandi, Giorgio Berardi
-
Patent number: 8377662Abstract: The document describes a process for the preparation of N-Acyl-Phosphatidyl-Ethanolamine of formula (I) on an industrial scale, In which R1, R2 and R3 are, independently from each other, saturated, monounsaturated or polyunsaturated acyls C10-C30, pure or mixed together, and X?OH or OM, where M=alkaline metal or alkaline earth, ammonium or alkylammonium. The process in question allows the conversion of lecithin of synthetic or natural origin into N-Acyl-Phosphatidyl-Ethanolamine of formula (I) of high purity, using a limited molar excess of the reagent N-acyl-ethanolamine, where the acyl is as defined above for the formula (I) through reaction of transphosphatidylation in the presence of the enzyme phospholipase D and in conditions suitable for production on an industrial scale.Type: GrantFiled: July 8, 2008Date of Patent: February 19, 2013Assignee: Chemi S.p.A.Inventors: Lorenzo De Ferra, Mauro Anibaldi, Ettore Ammirati
-
Patent number: 8232392Abstract: Described is a new process for producing temozolomide, comprising the reaction between 5-aminoimidazole-4-carboxamide and N-succinimidyl-N?-methyl carbamate and the subsequent reaction of the thus obtained carbamoyl 5-aminoimidazole-4-carboxamide with sodium nitrite. Temozolomide is then purified by chromatography on adsorbent polymeric resin and subsequent crystallization from water and acetone.Type: GrantFiled: July 30, 2009Date of Patent: July 31, 2012Assignee: Chemi S.p.A.Inventors: Stefano Turchetta, Lorenzo De Ferra, Maurizio Zenoni, Mauro Anibaldi
-
Publication number: 20110245485Abstract: Described herein is a process for the synthesis of azacitidine or decitabine, comprising the silylation of azacytosine in the presence of N,O-bis-trimethylsilyl-trifluoroacetamide. Such reaction is performed in an organic solvent, preferably aprotic, even more preferably selected from among dichloromethane, dichloroethane and/or acetonitrile. According to a further aspect of the process, 2 to 3 moles of N,O-bis-trimethylsilyl-trifluoroacetamide are used per mole of azacytosine, preferably from 2.2 to 2.5.Type: ApplicationFiled: March 28, 2011Publication date: October 6, 2011Applicant: CHEMI SPAInventors: Lorenzo DE FERRA, Maurizio ZENONI, Stefano TURCHETTA, Mauro ANIBALDI, Ettore AMMIRATI, Paolo BRANDI, Giorgio BERARDI
-
Publication number: 20110111469Abstract: The document describes a process for the preparation of N-Acyl-Phosphatidyl-Ethanolamine of formula (I) on an industrial scale, In which R1, R2 and R3 are, independently from each other, saturated, monounsaturated or polyunsaturated acyls C10-C30, pure or mixed together, and X=OH or OM, where M=alkaline metal or alkaline earth, ammonium or alkylammonium. The process in question allows the conversion of lecithin of synthetic or natural origin into N-Acyl-Phosphatidyl-Ethanolamine of formula (I) of high purity, using a limited molar excess of the reagent N-acyl-ethanolamine, where the acyl is as defined above for the formula (I) through reaction of transphosphatidylation in the presence of the enzyme phospholipase D and in conditions suitable for production on an industrial scale.Type: ApplicationFiled: July 8, 2008Publication date: May 12, 2011Applicant: CHEMI S.P.A.Inventors: Lorenzo De Ferra, Mauro Anibaldi, Ettore Ammirati
-
Publication number: 20100036121Abstract: Described is a new process for producing temozolomide, comprising the reaction between 5-aminoimidazole-4-carboxamide and N-succinimidyl-N?-methyl carbamate and the subsequent reaction of the thus obtained carbamoyl 5-aminoimidazole-4-carboxamide with sodium nitrite. Temozolomide is then purified by chromatography on adsorbent polymeric resin and subsequent crystallization from water and acetone.Type: ApplicationFiled: July 30, 2009Publication date: February 11, 2010Applicant: Chemi S.P.A.Inventors: Stefano Turchetta, Lorenzo De Ferra, Maurizio Zenoni, Mauro Anibaldi
-
Patent number: 7501533Abstract: Process for preparing lysophosphatidylcholine by selective monoacylation of glycerophosphorylcholine (1), in the presence of an acylating agent and of a dialkyltin derivative, according to the following diagram: The process is particularly simple and has high overall yields.Type: GrantFiled: December 6, 2005Date of Patent: March 10, 2009Assignee: Chem SpAInventors: Lorenzo De Ferra, Stefano Servi, Ezio Fasoli, Mauro Anibaldi, Daniele Scorretti
-
Publication number: 20070049637Abstract: A process for the synthesis of lipid cations having general formula (6): in which: R1 represents a lipophilic chain; R2, R3, R4, which are identical or different from one another, represent C1-C10 alkyl, C1-C10 alkenyl, or C1-C10 alkynyl radicals, optionally containing hydroxyl, ether, halogen and acyloxy functions, and X? is an oxy-anion or a halide; in which a compound of formula (2), in which R5 and R6, which are identical or different from one another, represent a C1-C5 acyl, a benzyl group or a diol-protective group, is reacted in an alcoholic solvent with from 1 to 6 equivalents of NR2R3R4.Type: ApplicationFiled: November 3, 2004Publication date: March 1, 2007Applicant: CHEMI SPAInventors: Lorenzo De Ferra, Mauro Anibaldi, Ettore Ammirati
-
Publication number: 20060079703Abstract: What is described is a process for preparing lysophosphatidylcholine by selective monoacylation of glycerophosphoryleholine (1), in the presence of an acylating agent and of dialkyltin derivatives, according to the following diagram: the process being particularly simple and having high overall yields.Type: ApplicationFiled: December 6, 2005Publication date: April 13, 2006Applicant: Chem SPAInventors: Lorenzo De Ferra, Stefano Servi, Ezio Fasoli, Mauro Anibaldi, Daniele Scorretti